HopeStage
Back to all studies
CompletedNCT00190684

Long-term atomoxetine safety and effects in children and adolescents with ADHD

About this titleRead the official source — NCT00190684

Researchers studied atomoxetine, tracking side effects to assess long-term safety in people with ADHD.

Medication studyAges 6–18Multiple countries
The study in practice

Understand this study

What did researchers investigate?

Researchers studied atomoxetine, tracking side effects to assess long-term safety in people with ADHD.

Who was this study for?

Listed age limits: 6 years to 18 years.

Listed locations
Birmingham and 99 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateAugust 2000
Recruitment status
Completed
Enrollment listed in the registry
1,553
Sponsor
Eli Lilly and Company
Sponsor type
Other organization
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, Australia, France, ...
Age range
From 6 Years to 18 Years
Official registry ID
NCT00190684
Official title
Show the full official title

Long-Term, Open Label Safety Study of Atomoxetine Hydrochloride in Patients, 6 Years and Older With Attention-Deficit/Hyperactivity Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Birmingham, United States · Phoenix, United States · El Centro, United States

95 more locations
  • Irvine, United States
  • Lafayette, United States
  • Los Angeles, United States
  • San Diego, United States
  • Spring Valley, United States
  • Walnut Creek, United States
  • Norwich, United States
  • Boca Raton, United States
  • Gainsville, United States
  • Miami, United States
  • Orlando, United States
  • Tallahassee, United States
  • West Palm Beach, United States
  • Boise, United States
  • Northbrook, United States
  • Indianapolis, United States
  • Iowa City, United States
  • Bardstown, United States
  • Lexington, United States
  • New Orleans, United States
  • Baltimore, United States
  • Cambridge, United States
  • Worcester, United States
  • Detroit, United States
  • Kalamazoo, United States
  • Troy, United States
  • St Louis, United States
  • Omaha, United States
  • Cherry Hill, United States
  • Clementon, United States
  • Moorestown, United States
  • Piscataway, United States
  • Manhasset, United States
  • New Hyde Park, United States
  • New York, United States
  • Rochester, United States
  • Stony Brook, United States
  • Chapel Hill, United States
  • Charlotte, United States
  • Durham, United States
  • Cincinnati, United States
  • Cleveland, United States
  • Columbus, United States
  • Oklahoma City, United States
  • Portland, United States
  • Hershey, United States
  • Media, United States
  • Philadelphia, United States
  • Pittsburgh, United States
  • Rydal, United States
  • Providence, United States
  • Nashville, United States
  • Dallas, United States
  • Galveston, United States
  • Lake Jackson, United States
  • Salt Lake City, United States
  • Fairfax, United States
  • Herndon, United States
  • Midlothian, United States
  • Norfolk, United States
  • Richmond, United States
  • Vienna, United States
  • Spokane, United States
  • Marshfield, United States
  • Middleton, United States
  • Milwaukee, United States
  • Wallsend, Australia
  • South Brisbane, Australia
  • West Perth, Australia
  • Antwerp, Belgium
  • Leuven, Belgium
  • Edmonton, Canada
  • Halifax, Canada
  • Toronto, Canada
  • Québec, Canada
  • Bordeaux, France
  • Lyon, France
  • Paris, France
  • Heiligenstadt/Ofr, Germany
  • Mannheim, Germany
  • Holon, Israel
  • Ness Ziona, Israel
  • Cagliari, Italy
  • Pisa, Italy
  • Groningen, Netherlands
  • Utrecht, Netherlands
  • Oslo, Norway
  • Rio Piedras, Puerto Rico
  • San Juan, Puerto Rico
  • Benmore, South Africa
  • Garsfontein, South Africa
  • Panorama, South Africa
  • Gothenburg, Sweden
  • Glasgow, United Kingdom
  • Sheffield, United Kingdom

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

Researchers studied atomoxetine, tracking side effects to assess long-term safety in people with ADHD.

Who is behind this study?

The study sponsor is Eli Lilly and Company.

Did this study involve medication?

Yes. The study involved medication, including atomoxetine.

Who was this study for?

Listed age limits: 6 years to 18 years.

Want to explore more studies?

Explore studies